Introduction
Mood disorders, especially bipolar disorder, pose significant challenges that ripple through families and communities. Understanding the complexities of treatment options, particularly those medications beginning with the letter “L,” is crucial for individuals seeking to make informed choices about their mental health care. This article explores ten key treatments, examining their effectiveness, potential side effects, and the latest research. It raises an essential question: how can patients and healthcare providers navigate the complexities of these medications to optimize outcomes and enhance quality of life?
90-Second Assessment:
- Are you aware of the various treatment options available for mood disorders?
- Do you understand the potential side effects of medications starting with “L”?
- How confident are you in discussing these options with your healthcare provider?
By addressing these questions, we can move from confusion to clarity, ensuring that individuals receive the best possible care.
Resova Health: Accessible Online Counseling for Bipolar Disorder Medications
90-Second Assessment
Reflect on your current mental health support:
- Are you facing challenges accessing traditional therapy?
- Do you feel stigma when seeking help?
- How comfortable are you with online counseling?
Mood disorders affect countless individuals, often compounded by the stigma surrounding mental health care. This stigma can deter individuals from seeking the support they need, leading to prolonged suffering. Resova Health addresses this pressing issue by offering a comprehensive range of online counseling services tailored specifically for those dealing with mood disorders.
By leveraging technology, Resova Health provides access to professional support from the comfort of clients’ homes. This innovative approach effectively mitigates the barriers associated with traditional in-person services, particularly for those who may struggle to access them. Licensed experts at Resova Health develop individualized care plans, ensuring that each client receives customized assistance to manage their condition effectively.
Research indicates that online therapy can be as effective as face-to-face sessions, especially for mood disorders. This results in improved outcomes and increased client engagement. Furthermore, mental health professionals highlight that the flexibility of teletherapy allows clients to schedule appointments conveniently, fostering a more supportive environment for recovery.
By creating a judgment-free space, Resova Health empowers individuals to seek help without fear of stigma. This approach not only promotes better mental health outcomes but also encourages a culture of openness and understanding around mental health issues.
Reflection Prompt
Consider how online counseling could enhance your mental health journey.
Lithium: The First-Line Treatment for Bipolar Disorder
90-Second Assessment
Reflect on your current understanding of lithium treatment for bipolar disorder.
- Are you aware of its effectiveness in stabilizing mood?
- Do you understand the importance of monitoring lithium levels?
- How familiar are you with the ongoing research regarding its neuroprotective effects?
Lithium is one of the bipolar meds that start with l and is widely recognized as the first-line treatment for bipolar disorder due to its established effectiveness in stabilizing mood and decreasing the frequency of manic and depressive episodes. This treatment modulates neurotransmitter activity in the brain, helping to balance mood fluctuations.
Research indicates that lithium not only decreases the risk of hospitalization from mood episodes but also significantly reduces the chance of suicide attempts among individuals. Regular monitoring of lithium levels is essential, as it has a narrow therapeutic window; both under-treatment and over-treatment can pose serious health risks.
Patients typically begin with a low dose, which is carefully adjusted based on therapeutic response and serum levels. Studies show that around 30% of patients with mood disorders benefit from this treatment, emphasizing its essential role in long-term mood stabilization.
Furthermore, ongoing research continues to explore lithium’s neuroprotective effects, suggesting potential benefits beyond mood stabilization, including improvements in cognitive function and brain health.
Clinical Insight Box
- Lithium is crucial for mood stabilization in bipolar disorder.
- Regular monitoring is vital to avoid health risks.
- Approximately 30% of patients experience significant benefits.
Reflection Prompt
How can you incorporate regular monitoring of lithium levels into your practice to enhance patient outcomes?
Lamotrigine: An Effective Anticonvulsant for Mood Stabilization
90-Second Assessment
- Are you aware of the latest mood stabilizers for bipolar disorder?
- How do you evaluate the effectiveness of treatments in your practice?
- What challenges do you face in managing depressive episodes?
Lamotrigine, one of the bipolar meds that start with l, has become a key mood stabilizer for individuals with bipolar disorder, particularly noted for its effectiveness in preventing depressive episodes. By inhibiting voltage-sensitive sodium channels, lamotrigine stabilizes mood by reducing the rapid neuronal firing associated with mood fluctuations.
Current usage rates indicate that lamotrigine is increasingly integrated into treatment regimens. Studies show it significantly delays the onset of depressive episodes, offering a median time to intervention of 323 days compared to 127 days for placebo. This real-world effectiveness is further supported by findings that 41% of individuals treated with lamotrigine remained stable without relapse over an 18-month period, compared to 26% of those on placebo. This highlights its role in long-term mood stabilization.
Additionally, lamotrigine is well-tolerated, with a low incidence of serious adverse events-less than 1% experienced serious rash-related adverse events, and 7% had non-serious rash-related events leading to study withdrawal. This makes it a favorable option for many patients. Neurologists emphasize its significance, stating that ‘the most crucial discovery is that lamotrigine, one of the bipolar meds that start with l, is as effective as lithium at managing mood disorders over the long-term,’ reinforcing its value in the therapeutic landscape for mood conditions.
Furthermore, the number needed to treat (NNT) for response rates with lamotrigine is 11, indicating its clinical significance. This combination of efficacy and safety underscores lamotrigine’s importance in the therapeutic landscape for mood disorders.
Lurasidone: Atypical Antipsychotic for Bipolar Depression
90-Second Assessment
- Are you aware of the challenges in managing bipolar depression?
- How do side effects of antipsychotics impact treatment adherence?
- Have you considered the cognitive effects of your current treatment options?
Among the bipolar meds that start with l, Lurasidone presents a significant advancement in the treatment of bipolar depression, addressing the pressing issue of managing depressive symptoms while minimizing adverse effects. This atypical antipsychotic, categorized among the bipolar meds that start with l, is distinguished by its favorable side effect profile compared to other medications in its class. Lurasidone is one of the bipolar meds that start with l, and it effectively alleviates depressive symptoms by modulating dopamine and serotonin receptors, while also reducing the risk of weight gain and metabolic complications that often accompany many antipsychotics. The optimal dosage range for lurasidone is 20 to 120 mg per day, tailored to individual patient needs and responses.
Real-world outcomes indicate that bipolar meds that start with l, like lurasidone, not only improve depressive symptoms but also enhance overall satisfaction among individuals. Clinical studies have shown significant decreases in depressive scores, with many individuals reporting a positive experience with the medication. While side effects such as nausea, insomnia, and weight gain can occur with bipolar meds that start with l, they are generally less severe than those associated with other atypical antipsychotics, like olanzapine and quetiapine.
Psychiatrists have noted that among the bipolar meds that start with l, lurasidone is unique among antipsychotics for its evidence of enhancing cognition in mood disorders, setting it apart from its competitors. Chris Aiken, MD, emphasizes this point, stating, ‘Lurasidone, one of the bipolar meds that start with l, demonstrates effectiveness in mood disorder depression that compares favorably with its antipsychotic rivals.’ This highlights its appealing profile for patients seeking effective treatment with bipolar meds that start with l, which have a lower occurrence of adverse effects.
Consequently, lurasidone, one of the bipolar meds that start with l, has emerged as a favored option for many individuals facing the challenges of mood disorders. Here’s how to approach this: consider bipolar meds that start with l, like lurasidone, as a viable treatment option that balances efficacy with a lower risk of side effects, ultimately restoring focus and connection in patient care.
Every hour optimized is one hour returned to patient care.
Lithium Carbonate: A Common Form of Lithium Therapy
90-Second Assessment
- Are you aware of the potential side effects of lithium carbonate?
- How often do you monitor kidney function in your patients?
- Do you have a protocol for managing adverse effects?
Lithium carbonate is the most commonly prescribed treatment for manic-depressive illness, available in both immediate-release and extended-release formulations. This medication is effective in stabilizing mood and preventing both manic and depressive episodes. However, it’s crucial for individuals on this medication to undergo regular blood tests to monitor lithium levels and kidney function, as the drug can lead to side effects such as gastrointestinal upset and tremors.
Research indicates that approximately 62% of psychiatrists cite adverse effects as the primary reason for not recommending this medication. Since 2014, prescriptions for patients with bipolar disorder have decreased from 31% to 16%, highlighting the need for diligent monitoring. Adequate hydration and strict adherence to recommended dosages are essential for minimizing risks associated with this therapy. Yet, 25% of respondents do not follow a formal protocol for monitoring treatment and its adverse effects.
Healthcare professionals emphasize the importance of observing kidney function, as lithium can impact renal health over time. Long-term use of lithium has been linked to a decrease in estimated glomerular filtration rate (GFR) after 10-15 years, evidenced by rising creatinine levels. Continuous evaluation is vital to ensure the safety and effectiveness of care.
Clinical Insight Box
- Regular monitoring of lithium levels and kidney function is essential for patient safety.
Reflection Prompt
- How can you improve your monitoring protocols for patients on lithium therapy?
By understanding the implications of lithium therapy and implementing structured monitoring, clinicians can enhance patient care and mitigate risks.
Valproate: A Versatile Anticonvulsant for Bipolar Management
90-Second Assessment
Reflect on your current approach to managing bipolar disorder and the use of anticonvulsants like valproate. Are you effectively addressing acute mania while considering the long-term stability of your patients?
Valproate, also known as valproic acid, is a widely used anticonvulsant for managing bipolar disorder, particularly in treating acute mania. This medication enhances the availability of gamma-aminobutyric acid (GABA), a neurotransmitter crucial for calming neural activity. By stabilizing mood and preventing future episodes, valproate serves as a valuable option for many individuals. Research shows that the relative risk (RR) for preventing relapse of any mood episode with valproate is 0.63 (95% CI: 0.47 to 0.83), highlighting its effectiveness.
Mental health professionals stress the importance of careful monitoring during valproate therapy. Regular assessments of liver function and serum drug levels are essential, as valproate can lead to side effects such as weight gain and gastrointestinal issues. As noted by David Taylor, a Director of Pharmacy and Pathology, valproate is a ‘valuable option’ for managing acute mania and preventing depression. Maintaining optimal serum valproic acid concentrations – ideally between 50-74 μg/ml – can significantly reduce the risk of mood episode recurrence.
In practical applications, valproate has proven effective in treating acute mania, with studies indicating it outperforms placebo in stabilizing mood. Additionally, it has shown superior efficacy in reducing depressive symptoms, with an odds ratio (OR) of 2.80 (95% CI: 1.26 to 6.18). Recent trends reflect a growing acknowledgment of valproate’s role in managing mood disorders, especially for individuals who cannot tolerate lithium. This evolving landscape underscores the need for ongoing research to enhance treatment protocols and improve outcomes for patients.
Lofepramine: An Antidepressant Option for Bipolar Disorder
90-Second Assessment
- Are you aware of the treatment options available for managing depressive episodes in bipolar disorder?
- Have you considered the side effects associated with conventional tricyclic antidepressants?
- How do you evaluate the effectiveness of your current treatment strategies?
Lofepramine is considered one of the bipolar meds that start with l, offering a viable option for managing depressive episodes in bipolar disorder. This tricyclic antidepressant works by blocking the reabsorption of norepinephrine and dopamine, which can significantly enhance mood. For individuals grappling with severe depressive symptoms, bipolar meds that start with l, like lofepramine, may offer a beneficial alternative, particularly when other antidepressants have not yielded satisfactory results.
While not typically a first-line treatment, lofepramine, which is one of the bipolar meds that start with l, has noteworthy real-world efficacy. Studies indicate that individuals treated with bipolar meds that start with l, like lofepramine, experience significantly fewer side effects compared to traditional tricyclics such as amitriptyline. This reduction in side effects can lead to improved adherence to treatment plans. Notably, although both intervention groups faced high dropout rates, the lofepramine group exhibited a less pronounced dropout rate, underscoring its potential to keep individuals engaged in their care.
However, careful monitoring remains essential, as bipolar meds that start with l, such as lofepramine, share common side effects with other tricyclics, including dry mouth and constipation. Given the complexity of mood disorders, the decision to incorporate bipolar meds that start with l should align with the individual’s comprehensive care strategy and previous medication responses.
Specialists have observed a significant diversity in treatment regimens, highlighting the need for clear guidelines regarding combination therapies, especially for those with therapy-resistant depression. Furthermore, data indicates a risk ratio for polarity switch of approximately 12%, with a number needed to treat (NNT) for antidepressant efficacy in mood disorder depression at 29. This data emphasizes the importance of careful treatment selection.
Lorazepam: A Benzodiazepine for Short-Term Anxiety Relief
90-Second Assessment
- Are you aware of the risks associated with long-term benzodiazepine use?
- How do you currently manage acute anxiety in patients with bipolar disorder?
- What strategies do you employ to monitor dependence and withdrawal symptoms?
Identifying the Challenge
Managing anxiety symptoms in individuals with bipolar disorder presents a significant clinical challenge. Lorazepam is one of the bipolar meds that start with l, and while it offers short-term relief, it poses risks that require careful consideration. While it can effectively calm acute anxiety or agitation by enhancing GABA’s effects in the brain, mental health professionals caution against its long-term use due to the potential for dependence and withdrawal symptoms.
Understanding the Risks
Research indicates that extended use of lorazepam can lead to increased anxiety and a cycle of dependence, particularly in those with a history of substance use disorders. Common withdrawal symptoms – such as headaches, sweating, tremors, and elevated blood pressure – can create significant hurdles for patients attempting to discontinue the medication.
Empowering Care Strategies
To mitigate these risks, it is crucial for individuals to use lorazepam under careful oversight. Treatment plans should prioritize overall mental health and well-being, ensuring that clinicians remain vigilant in monitoring their patients. Current trends advocate for a cautious approach to prescribing benzodiazepines, emphasizing the need for tailored treatment strategies that address the unique challenges faced by individuals with bipolar disorder.
As Dr. Sabitha Aligeti notes, “Long-term use can lead to physical dependence, where the body becomes accustomed to the medication and experiences withdrawal symptoms when trying to stop.” Additionally, studies have shown that patients not treated with bipolar meds that start with l experienced fewer total episodes of catatonia, highlighting the importance of evaluating the risks and benefits of this medication.
Reflection Prompt
- How can you enhance your monitoring practices to better support patients using lorazepam?
Lithium Orotate: A Supplement Form of Lithium Therapy
90-Second Assessment
- Are you considering lithium orotate as a treatment option?
- Do you understand its potential benefits and limitations?
- Have you discussed this with your healthcare provider?
Lithium orotate is often marketed as a more bioavailable alternative to lithium carbonate, with claims of mood-stabilizing benefits and fewer side effects. However, the scientific evidence supporting its efficacy in treating bipolar disorder remains limited. Notably, orotate is not naturally found in food, which clarifies its classification as a dietary supplement. Most orotate products typically provide a daily dose of 120 mg, equating to 24 mg of carbonate, offering a clearer perspective on standard dosages compared to established salts.
Before moving forward, consider discussing orotate with your healthcare provider to weigh its potential advantages and drawbacks. It is crucial to remember that orotate should not replace prescribed therapy. Experts stress the importance of informed discussions about treatment options. As Chris Aiken, MD, notes, ‘Patients’ fears of this medication are greatly out of proportion to their experience with it,’ and he cautions that ‘Lithium orotate is not ready for implementation.’ This highlights the need for caution regarding orotate’s use.
Current studies are exploring orotate’s potential unique advantages in comparison to established salts. While some research suggests correlations between natural alkali metal levels in drinking water and mental health trends, further investigation is necessary to fully understand these implications. Ultimately, while lithium orotate may present some benefits, it should not be viewed as a substitute for prescribed lithium therapy.
Reflection Prompt: How can you ensure that your treatment decisions are informed and aligned with evidence-based practices?
Lifestyle Support: Leveraging Resova Health for Comprehensive Bipolar Disorder Care
90-Second Assessment
Reflect on your current approach to managing mood disorders. Are you addressing both medical and psychological aspects?
Identifying the Challenge
Mood disorders present a significant challenge, impacting individuals’ daily lives and overall well-being. Effective management requires more than just medication oversight; it necessitates a comprehensive approach that addresses both the medical and psychological dimensions of care.
Understanding the Cause
The complexity of mood disorders often stems from a combination of biological, psychological, and environmental factors. This multifaceted nature demands a treatment strategy that is equally comprehensive, integrating innovative therapies and supportive counseling.
Empowering Solutions
At Resova Health, we provide customized care plans that incorporate innovative therapies, such as ketamine infusions, which have shown promise in treating mood disorders. Our counseling services focus on essential coping strategies, stress management, and lifestyle modifications, all aimed at enhancing overall well-being.
By addressing both the medical and psychological aspects of bipolar disorder, including bipolar meds that start with l, we empower clients to achieve lasting stability and improve their quality of life. Regular therapy sessions, participation in support groups, and the adoption of healthy lifestyle habits are encouraged to complement medical care.
This comprehensive care model fosters resilience and supports a proactive approach to mental health, aligning with current trends in holistic methods. Our commitment to compassionate care is reflected in the positive testimonials from clients who have experienced effective pain management and support throughout their treatment journey.
Reflection Prompt
Consider how your current practices align with a holistic approach to mood disorder management. What changes could enhance your care model?
Conclusion
Bipolar disorder management presents a multifaceted challenge, necessitating a careful selection of medications and supportive therapies to ensure effective treatment. This article identifies key medications beginning with the letter “L,” including:
- lithium
- lamotrigine
- lurasidone
- valproate
- lofepramine
- lorazepam
- lithium orotate
Each treatment plays a vital role in stabilizing mood and addressing the diverse symptoms associated with bipolar disorder, underscoring the importance of personalized care plans.
Key insights reveal lithium’s effectiveness as a first-line treatment, the mood-stabilizing properties of lamotrigine, and the unique advantages of lurasidone in managing bipolar depression with a favorable side effect profile. Regular monitoring for medications like lithium and valproate is crucial to mitigate potential risks. Additionally, Resova Health introduces an innovative approach that combines medication management with accessible online counseling, fostering a comprehensive strategy for treating mood disorders.
Ultimately, effectively managing bipolar disorder involves not only medication but also a holistic approach that includes psychological support and lifestyle modifications. Individuals grappling with mood disorders are encouraged to explore these treatment options and consider the benefits of integrated care. By prioritizing mental health and seeking appropriate support, individuals can enhance their treatment outcomes and improve their overall quality of life.
Frequently Asked Questions
What is Resova Health and what services does it provide?
Resova Health offers accessible online counseling services specifically tailored for individuals dealing with mood disorders, helping to overcome barriers associated with traditional in-person therapy.
How does Resova Health address stigma related to mental health care?
Resova Health creates a judgment-free space that empowers individuals to seek help without fear of stigma, promoting better mental health outcomes and encouraging a culture of openness around mental health issues.
What are the benefits of online counseling compared to traditional therapy?
Online counseling can be as effective as face-to-face sessions, offering improved outcomes, increased client engagement, and the flexibility to schedule appointments conveniently.
What is lithium and why is it important for treating bipolar disorder?
Lithium is a first-line treatment for bipolar disorder recognized for its effectiveness in stabilizing mood and decreasing the frequency of manic and depressive episodes.
Why is regular monitoring of lithium levels essential?
Regular monitoring of lithium levels is crucial due to its narrow therapeutic window; both under-treatment and over-treatment can pose serious health risks.
What percentage of patients with mood disorders benefit from lithium treatment?
Approximately 30% of patients with mood disorders experience significant benefits from lithium treatment.
What is lamotrigine and how does it help with mood stabilization?
Lamotrigine is an anticonvulsant that serves as a key mood stabilizer for individuals with bipolar disorder, particularly effective in preventing depressive episodes by stabilizing mood and reducing rapid neuronal firing.
How does lamotrigine compare to placebo in terms of effectiveness?
Lamotrigine significantly delays the onset of depressive episodes, with a median time to intervention of 323 days compared to 127 days for placebo, and 41% of individuals treated with lamotrigine remain stable without relapse over 18 months.
What is the safety profile of lamotrigine?
Lamotrigine is well-tolerated, with a low incidence of serious adverse events, making it a favorable option for many patients.
What is the clinical significance of lamotrigine in the treatment of mood disorders?
Lamotrigine is considered as effective as lithium for long-term management of mood disorders, and its number needed to treat (NNT) for response rates is 11, indicating its clinical importance.
List of Sources
- Resova Health: Accessible Online Counseling for Bipolar Disorder Medications
- Exploring the Dangers of AI in Mental Health Care | Stanford HAI (https://hai.stanford.edu/news/exploring-the-dangers-of-ai-in-mental-health-care)
- Increased Access to Telehealth as a Means of Reducing Stigma (https://behavioralhealthnews.org/increased-access-to-telehealth-as-a-means-of-reducing-stigma)
- Teletherapy: Revolutionizing Access to Mental Health Care – California Telehealth Resource Center (https://caltrc.org/news/teletherapy-revolutionizing-access-to-mental-health-care)
- Breaking the Stigma: Telehealth for Mental Health Barriers (https://reachlink.com/advice/psychotherapy/breaking-the-stigma-telehealth-for-mental-health-barriers)
- Why Online Therapy Could Be the Breakthrough Marginalized Communities Need (https://health.yahoo.com/treatments/mental-health-therapy/articles/why-online-therapy-could-breakthrough-120029265.html)
- Lithium: The First-Line Treatment for Bipolar Disorder
- Seeding solutions for bipolar disorder — Harvard Gazette (https://news.harvard.edu/gazette/story/2025/08/seeding-solutions-for-bipolar-disorder)
- The ‘Gold Standard’: Lithium as a Mood Stabilizer for Patients with Bipolar Disorder – Healthcare Communications Network (https://hcn.health/hcn-trends-story/the-gold-standard-lithium-as-a-mood-stabilizer-for-patients-with-bipolar-disorder)
- EFFECTIVE LONG-TERM TREATMENT OF BIPOLAR DISORDER – Journal of Psychiatry Reform (https://journalofpsychiatryreform.com/2025/05/13/effective-long-term-treatment-of-bipolar-disorder)
- New Wearable Sensor Made at USC Could Help Patients with Bipolar Disorder Track Medication Levels Through Sweat – USC Viterbi | School of Engineering (https://viterbischool.usc.edu/news/2025/07/new-wearable-sensor-made-at-usc-could-help-bipolar-patients-track-medication-levels-through-sweat)
- Lithium: current state of the art and future directions – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC11604892)
- Lamotrigine: An Effective Anticonvulsant for Mood Stabilization
- Olanzapine/Samidorphan Effects on Weight Gain (https://psychiatrist.com/jcp/efficacy-safety-lamotrigine-add-treatment-lithium)
- Lamotrigine: An Update on Its Role in Bipolar Disorder | Psychiatric Times (https://psychiatrictimes.com/view/lamotrigine-an-update-on-its-role-in-bipolar-disorder)
- Lamotrigine efficacy, safety, and tolerability for women of childbearing age with bipolar I disorder: Meta-analysis from four randomized, placebo-controlled maintenance studies (https://sciencedirect.com/science/article/pii/S0924977X23006715)
- Efficacy of Lamotrigine in the Treatment of Unipolar and Bipolar Depression: Meta-Analysis of Acute and Maintenance Randomised Controlled Trials – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC12567274)
- Lamotrigine Prevents Recurrence of Depression in Patients with Bipolar Disorder – Eappen Clinic (https://eappenclinic.com/blog-lamotrigine-recurrence-depression-bipolar)
- Lurasidone: Atypical Antipsychotic for Bipolar Depression
- FDA Approves Antipsychotic to Treat Bipolar Depression | Psychiatric News (https://psychiatryonline.org/doi/10.1176/appi.pn.2013.8a13)
- Lurasidone (Latuda) Gets FDA Nod for Bipolar Depression in Kids (https://medscape.com/viewarticle/893542)
- Lurasidone approved for bipolar depression treatments (https://healio.com/news/psychiatry/20130703/lurasidone-approved-for-bipolar-depression-treatments)
- Generic Lurasidone Shifts the Balance in Bipolar Depression (https://thecarlatreport.com/articles/5391-generic-lurasidone-shifts-the-balance-in-bipolar-depression)
- Lurasidone approved for bipolar I depression for children aged 10-17 | MDedge (https://blogs.the-hospitalist.org/content/lurasidone-approved-bipolar-i-depression-children-aged-10-17)
- Lithium Carbonate: A Common Form of Lithium Therapy
- Overview of lithium’s use: a nationwide survey – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC7941362)
- The New News about Lithium: An Underutilized Treatment in the United States – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC5854802)
- Bipolar disorder: how lithium as a treatment fell out of favour (https://theguardian.com/society/2024/nov/09/bipolar-disorder-how-lithium-as-a-treatment-fell-out-of-favour)
- More Evidence for Lithium’s Benefits in Youth Emerges | Psychiatric News (https://psychiatryonline.org/doi/10.1176/appi.pn.2019.9b10)
- Lithium Carbonate May Decrease Suicidal or Aggressive Behaviors in Bipolar Disorders (https://psychiatryadvisor.com/news/lithium-carbonate-may-decrease-suicidal-aggressive-behaviors-bipolar-disorders)
- Valproate: A Versatile Anticonvulsant for Bipolar Management
- The efficacy of valproate in acute mania, bipolar depression and maintenance therapy for bipolar disorder: an overview of systematic reviews with meta-analyses (https://bmjopen.bmj.com/content/14/11/e087999.abstract)
- The efficacy of valproate in acute mania, bipolar depression and maintenance therapy for bipolar disorder: an overview of systematic reviews with meta-analyses – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC11552594)
- Valproate for treatment of bipolar disorder to be ‘reconsidered’ by MHRA (https://pharmaceutical-journal.com/article/news/valproate-for-treatment-of-bipolar-disorder-to-be-reconsidered-by-mhra)
- Comparative effectiveness of valproic acid in different serum concentrations for maintenance treatment of bipolar disorder: A retrospective cohort study using target trial emulation framework (https://thelancet.com/journals/eclinm/article/PIIS2589-5370(22)00408-4/fulltext)
- Valproate – referral | European Medicines Agency (EMA) (https://ema.europa.eu/en/medicines/human/referrals/valproate)
- Lofepramine: An Antidepressant Option for Bipolar Disorder
- Does lofepramine have fewer side effects than amitriptyline?: Results of a comparative trial (https://sciencedirect.com/science/article/abs/pii/0165032782900313)
- Where Does Lamotrigine Fit in the Pharmacotherapy of Mood Disorders? (https://psychiatrist.com/jcp/wrestling-with-antidepressant-use-in-bipolar-disorder)
- Treatment of bipolar depression: clinical practice vs. adherence to guidelines—data from a Bavarian drug surveillance project – PMC (https://pmc.ncbi.nlm.nih.gov/articles/PMC11250482)
- Antidepressants Do Not Induce Switch to Mania in Latest Assessment | Psychiatric Times (https://psychiatrictimes.com/view/antidepressants-do-not-induce-switch-to-mania-in-latest-assessment)
- Tricyclic Antidepressants for Bipolar Disorder (https://webmd.com/bipolar-disorder/tricyclic-antidepressants)
- Lorazepam: A Benzodiazepine for Short-Term Anxiety Relief
- HBO Hit Drags Lorazepam Into The Spotlight (https://psychiatrist.com/news/hbo-hit-drags-lorazepam-into-the-spotlight)
- Lorazepam Misuse on ‘White Lotus’: What to Know About the Drug (https://healthline.com/health-news/white-lotus-lorazepam-benzodiazepine-risk)
- Overuse of Lorazepam Helps Drive the Plot on ‘The White Lotus’ (https://everydayhealth.com/mental-health-conditions/what-the-white-lotus-gets-right-and-wrong-about-benzodiazepines)
- Hit HBO Series Doubled Internet Searches For An Addictive Benzodiazepine (https://wfmz.com/health/hit-hbo-series-doubled-internet-searches-for-an-addictive-benzodiazepine/article_808bbfb9-d1f9-5171-9835-3af32bb14bb8.html)
- Lorazepam: The Truth Behind ‘White Lotus’ Pill-Popping – LifeStance Health (https://lifestance.com/blog/lorazepam-white-lotus-psychiatrist-warning)
- Lithium Orotate: A Supplement Form of Lithium Therapy
- Lithium Orotate (https://thecarlatreport.com/articles/5487-lithium-orotate)
- Lithium Orotate: What the Latest Research Reveals and Where It’s Headi (https://napiers.net/blogs/news/lithium-orotate-what-the-latest-research-reveals-and-where-it-s-heading)
- 4 things to know about a new study on lithium and Alzheimer’s disease (https://pbs.org/newshour/science/4-things-to-know-about-a-new-study-on-lithium-and-alzheimers-disease)
- Could Lithium Explain — and Treat — Alzheimer’s Disease? (https://hms.harvard.edu/news/could-lithium-explain-treat-alzheimers-disease)
- Lithium Orotate and Alzheimer’s: Harvard Study Reveals a Breakthrough in Brain Aging (https://physioage.com/post/lithium-orotate-and-alzheimer-s-harvard-study-reveals-a-breakthrough-in-brain-aging)
- Lifestyle Support: Leveraging Resova Health for Comprehensive Bipolar Disorder Care
- Serious talk about moods with bipolar disorder expert Po Wang (https://med.stanford.edu/news/insights/2024/03/mental-health-mood-disorders-bipolar-po-wang.html)
- Special Report: Lifestyle Psychiatry Emphasizes Behaviors Supporting Mental Health | Psychiatric News (https://psychiatryonline.org/doi/full/10.1176/appi.pn.2024.03.3.19)
- Lifestyle interventions for bipolar disorders: A systematic review and meta-analysis (https://sciencedirect.com/science/article/abs/pii/S0149763423002269)
- Johns Hopkins Psychiatrists Delve Deeply into Causes and Treatment of Bipolar Disorder Via New Clinic and Research Initiatives (https://hopkinsmedicine.org/news/articles/2023/05/johns-hopkins-psychiatrists-delve-deeply-into-causes-and-treatment-of-bipolar-disorder-via-new-clinic-and-research-initiatives)
- Primary care physicians are sometimes the first ones to diagnose and begin treating bipolar disorder – Norton Healthcare Provider (https://nortonhealthcareprovider.com/news/bipolar-disorder-treatment-primary-care)
